4324 items matching your search terms.

Prediction of pre-eclampsia in nulliparous women using routinely collected maternal characteristics: A model development and validation study

Al-Rubaie, Z. T. A. Hudson, H. M. Jenkins, G. Mahmoud, I. Ray, J. G. Askie, L. M. Lord, S. J.
BMC PREGNANCY CHILDBIRTH, 2020     DOI:10.1186/s12884-019-2712-x

Molecular and clonal evolution in recurrent metastatic gliosarcoma

Anderson, K. J. Tan, A. C. Parkinson, J. Back, M. Kastelan, M. Newey, A. Brewer, J. Wheeler, H. Hudson, A. L. Amin, S. B. Johnson, K. C. Barthel, F. P. Verhaak, R. G. W. Khasraw, M.
COLD SPRING HARB MOL CASE STUD, 2020     DOI:10.1101/mcs.a004671

Interventions commenced by early infancy to prevent childhood obesity - The EPOCH Collaboration: An individual participant data prospective meta-analysis of four randomized controlled trials

Askie, L. M. Espinoza, D. Martin, A. Daniels, L. A. Mihrshahi, S. Taylor, R. Wen, L. M. Campbell, K. Hesketh, K. D. Rissel, C. Taylor, B. Magarey, A. Seidler, A. L. Hunter, K. E. Baur, L. A.
PEDIATR OBES, 2020     DOI:10.1111/ijpo.12618

Lactoferrin infant feeding trial_Canada (LIFT_Canada): Protocol for a randomized trial of adding lactoferrin to feeds of very-low-birth-weight preterm infants

Asztalos, E. V. Barrington, K. Lodha, A. Tarnow-Mordi, W. Martin, A.
BMC PEDIATRICS, 2020     DOI:10.1186/s12887-020-1938-0

Pattern of failure in anaplastic glioma patients with an IDH1/2 mutation

Back, M. Jayamanne, D. Brazier, D. Newey, A. Bailey, D. Schembri, G. Hsiao, E. Khasraw, M. Wong, M. Kastelan, M. Brown, C. Wheeler, H.
STRAHLENTHERAPIE UND ONKOLOGIE, 2020     DOI:10.1007/s00066-019-01467-0

Association of bolus feeding with splanchnic and cerebral oxygen utilization efficiency among premature infants with anemia and after blood transfusion

Balegar, V. Kk Jayawardhana, M. Martin, A. J. de Chazal, P. Nanan, R. K. H.
JAMA NETW OPEN, 2020     DOI:10.1001/jamanetworkopen.2020.0149

Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): Results from a multicentre, randomised controlled phase II trial

Barbour, A. P. Walpole, E. T. Mai, G. T. Barnes, E. H. Watson, D. I. Ackland, S. P. Martin, J. M. Burge, M. Finch, R. Karapetis, C. S. Shannon, J. Nott, L. M. Varma, S. Marx, G. Falk, G. L. Gebski, V. Oostendorp, M. Wilson, K. Thomas, J. Lampe, G. Zalcberg, J. R. Simes, J. Smithers, B. M. Doctor investigators
ANNALS OF ONCOLOGY, 2020     DOI:10.1016/j.annonc.2019.10.019

The AGITG GAP Study: A phase II study of perioperative gemcitabine and nab-paclitaxel for resectable pancreas cancer

Barbour, A. P. Samra, J. S. Haghighi, K. S. Donoghoe, M. W. Burge, M. Harris, M. T. Chua, Y. J. Mitchell, J. O'Rourke, N. Chan, H. Gebski, V. J. Gananadha, S. Croagh, D. G. Kench, J. G. Goldstein, D. Australasian Gastro-Intestinal Trials Group, G. A. P. investigators
ANNALS OF SURGICAL ONCOLOGY, 2020     DOI:10.1245/s10434-020-08205-2

A microRNA signature in acute coronary syndrome patients and modulation by colchicine

Barraclough, J. Y. Joglekar, M. V. Januszewski, A. S. Martinez, G. Celermajer, D. S. Keech, A. C. Hardikar, A. A. Patel, S.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020     DOI:10.1177/1074248420922793

Interventions for congenital talipes equinovarus (clubfoot)

Bina, S. Pacey, V. Barnes, E. H. Burns, J. Gray, K.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020     DOI:10.1002/14651858.CD008602.pub4

Data integrity of 35 randomised controlled trials in women' health

Bordewijk, E. M. Wang, R. Askie, L. M. Gurrin, L. C. Thornton, J. G. van Wely, M. Li, W. Mol, B. W.
EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY, 2020     DOI:10.1016/j.ejogrb.2020.04.016

Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer

Bui, K. T. Willson, M. L. Goel, S. Beith, J. Goodwin, A.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020     DOI:10.1002/14651858.CD013538

Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study

Cao, J. Y. Waldman, B. O'Connell, R. Sullivan, D. R. Scott, R. S. Aryal, N. Gebski, V. Marschner, I. Taskinen, M. R. Simes, J. R. McGill, N. Jenkins, A. J. Keech, A. C. Field investigators
DIABETES, OBESITY AND METABOLISM, 2020     DOI:10.1111/dom.14046

The oncological survival and prognosis of individuals receiving PD-1 inhibitor with and without immunologic cutaneous adverse events

Chan, L. Hwang, S. J. E. Kyaw, M. Byth, K. Carlino, M. S. Chou, S. Fernandez-Penas, P.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020     DOI:10.1016/j.jaad.2019.06.035

Generating comparative evidence on new drugs and devices after approval

Cipriani, A. Ioannidis, J. P. A. Rothwell, P. M. Glasziou, P. Li, T. Hernandez, A. F. Tomlinson, A. Simes, J. Naci, H.
LANCET, 2020     DOI:10.1016/S0140-6736(19)33177-0